Reference number : 236-2018-2019-Q2-00528, amendment number : , agreement type : G, recipient legal name : Hafeez, Aneeka, recipient country : CA, recipient province : ON, recipient city : London, recipient postal code : N6A 3K7, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 17500.0, agreement start date : 2018-09-01, agreement end date : 2019-08-31, description english : Cost-effectiveness of Pharmacogenomic-guided (PGX) Approach to Warfarin Therapy among Patients diagnosed with Atrial Fibrillation: Experimental Evidence from Ontario, description french : Cost-effectiveness of Pharmacogenomic-guided (PGX) Approach to Warfarin Therapy among Patients diagnosed with Atrial Fibrillation: Experimental Evidence from Ontario, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada